Table 1.
Characteristics of interview participants.
Fig 1.
Dominant barriers, enablers and potential enablers affecting deprescribing engagement.
(MDT = multidisciplinary team, IT = information technology).
Table 2.
Dominant barriers (B), enablers (E), and potential enablers (PE) mapped to domains in the deprescribing framework.
Table 3.
Non-dominant barriers (B), enablers (E), and potential enablers (PE) mapped to domains in the deprescribing framework.
Table 4.
Analysis of public versus private opinions.